These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 19029184)

  • 1. Pharmacological targeting of the serotonergic system for the treatment of obesity.
    Garfield AS; Heisler LK
    J Physiol; 2009 Jan; 587(1):49-60. PubMed ID: 19029184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic serotonin in control of eating behavior, meal size, and body weight.
    Leibowitz SF; Alexander JT
    Biol Psychiatry; 1998 Nov; 44(9):851-64. PubMed ID: 9807640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors.
    Lam DD; Przydzial MJ; Ridley SH; Yeo GS; Rochford JJ; O'Rahilly S; Heisler LK
    Endocrinology; 2008 Mar; 149(3):1323-8. PubMed ID: 18039773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of 5-HT receptors in the regulation of food intake in Siberian hamsters.
    Schuhler S; Clark A; Joseph W; Patel A; Lehnen K; Stratford E; Horan TL; Fone KC; Ebling FJ
    J Neuroendocrinol; 2005 May; 17(5):276-85. PubMed ID: 15869562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the brain serotonin satiety system in transgenic rats lacking brain angiotensinogen.
    Voigt JP; Raasch W; Hörtnagl H; Bader M; Fink H; Jöhren O
    J Neuroendocrinol; 2008 Feb; 20(2):182-7. PubMed ID: 18047554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity.
    Halford JC; Harrold JA; Lawton CL; Blundell JE
    Curr Drug Targets; 2005 Mar; 6(2):201-13. PubMed ID: 15777190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic 5-HT2C receptor editing in a mouse model of obesity.
    Schellekens H; Clarke G; Jeffery IB; Dinan TG; Cryan JF
    PLoS One; 2012; 7(3):e32266. PubMed ID: 22448217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deconstructing antiobesity compound action: requirement of serotonin 5-HT2B receptors for dexfenfluramine anorectic effects.
    Banas SM; Doly S; Boutourlinsky K; Diaz SL; Belmer A; Callebert J; Collet C; Launay JM; Maroteaux L
    Neuropsychopharmacology; 2011 Jan; 36(2):423-33. PubMed ID: 20927048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin receptor ligands and the treatment of obesity.
    Vickers SP; Dourish CT
    Curr Opin Investig Drugs; 2004 Apr; 5(4):377-88. PubMed ID: 15134278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple serotonin receptors: opportunities for new treatments for obesity?
    Dourish CT
    Obes Res; 1995 Nov; 3 Suppl 4():449S-462S. PubMed ID: 8697043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic anti-obesity agents: past experience and future prospects.
    Halford JC; Boyland EJ; Lawton CL; Blundell JE; Harrold JA
    Drugs; 2011 Dec; 71(17):2247-55. PubMed ID: 22085383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT(2C) receptor agonists and the control of appetite.
    Halford JC; Harrold JA
    Handb Exp Pharmacol; 2012; (209):349-56. PubMed ID: 22249823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of serotonergic drugs to treat obesity--is there any hope?
    Bello NT; Liang NC
    Drug Des Devel Ther; 2011 Feb; 5():95-109. PubMed ID: 21448447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.
    Halford JC; Harrold JA; Boyland EJ; Lawton CL; Blundell JE
    Drugs; 2007; 67(1):27-55. PubMed ID: 17209663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleus of the Solitary Tract Serotonin 5-HT
    D'Agostino G; Lyons D; Cristiano C; Lettieri M; Olarte-Sanchez C; Burke LK; Greenwald-Yarnell M; Cansell C; Doslikova B; Georgescu T; Martinez de Morentin PB; Myers MG; Rochford JJ; Heisler LK
    Cell Metab; 2018 Oct; 28(4):619-630.e5. PubMed ID: 30146485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural satiety sequence (BSS): separating wheat from chaff in the behavioural pharmacology of appetite.
    Rodgers RJ; Holch P; Tallett AJ
    Pharmacol Biochem Behav; 2010 Nov; 97(1):3-14. PubMed ID: 20214921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats.
    Vickers SP; Benwell KR; Porter RH; Bickerdike MJ; Kennett GA; Dourish CT
    Br J Pharmacol; 2000 Jul; 130(6):1305-14. PubMed ID: 10903970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of serotonergic mechanisms in leptin-induced suppression of milk intake in mice.
    Yamada J; Sugimoto Y; Hirose H; Kajiwara Y
    Neurosci Lett; 2003 Sep; 348(3):195-7. PubMed ID: 12932826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenfluramine blocks low-Mg2+-induced epileptiform activity in rat entorhinal cortex.
    Gentsch K; Heinemann U; Schmitz B; Behr J
    Epilepsia; 2000 Aug; 41(8):925-8. PubMed ID: 10961615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
    Knobelman DA; Hen R; Blendy JA; Lucki I
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1092-100. PubMed ID: 11504806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.